As BIO Asia–Taiwan 2026 brought the region’s biotechnology and healthcare ecosystem together in Taip...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
Advancing Clinical Development and Evidence Generation Clinical development is entering a new era where success depends...
As cell and gene therapies progress from promising research to commercial reality, manufacturing has emerged as ...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
As antibody-drug conjugates (ADCs), bispecific antibodies and other advanced biologics redefine the global therapeutics ...
The rapid expansion of in vivo gene therapy is reshaping expectations for viral vector manufacturing, placing greater em...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
Research institutions generate groundbreaking discoveries every year, yet only a small fraction successfully reach patie...
Despite causing millions of serious infections and hundreds of thousands of deaths each year, fungal diseases continue t...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
Oklahoma City's life sciences ambitions are increasingly centred on advanced manufacturing, collaboration, and long-term...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Arthur Jackson...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Ella Woger-Nie...
While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As obesity treatment enters a new phase of innovation, the industry is increasingly looking beyond GLP-1 therapies to ad...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
